Residual risks of viral transmission by transfusions and projected yields of additionnal screening tests;Risques résiduels de transmission virale par transfusion et estimation de l'impact de tests supplémentaires de dépistage

Transfusion Clinique et Biologique

Volumn 3, Issue 1, 1996, Pages 7-11

  Busch, M P ^a  

^a Blood Centers of the Pacific   (United States)

Author keywords

Blood; HBV; HCV; Hepatitis B virus; Hepatitis C virus; HIV; HTLV; Human immunodeficiency virus; Human T lymphotropic virus; PCR; Polymerase chain reaction; Transfusion

Indexed keywords

VIRUS ANTIBODY;

ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOLOGY; INCIDENCE; MASS SCREENING; PHYSIOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; VIRUS INFECTION;

ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD TRANSFUSION; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; INCIDENCE; MASS SCREENING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; VIRUS DISEASES;

EID: 0029688310     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(96)80007-3     Document Type: Article

References (28)

1. Dodd R.Y. (1994) Adverse consequences of blood transfusion : quantitative risk estimates. Chapter 1 in Blood Supply : Risks. Perceptions and Prospects for the Future. Nance S.T., ed. Amer. Assn. of Blood Banks, Bethesda MD.
2. Kleinman S.H. (1992) Donor selection and screening procedures. Chapter 6 in Blood Safety : Current Challenges. Nance S.T., ed. Amer. Assn. of Blood Banks, Bethesda MD.
3. Kleinman S.H., Busch M.P. (1995) A general overview of transfusion transmitted infections. Introduction to : Clinical Practice of Transfusion Medicine 3rd ed. Petz L.D., Swisher S., Kleinman S.H., Spence R., Strauss R.G., Churchill Livingstone, New York (in press).
4. Alter H.J. (1995) To C or not to C : these are the questions. (Review) Blood, 85, 7, 1681-1695.
5. Selik R.M., Ward J.W., Buehler J.W. (1993) Trends in transfusion associated acquired immune deficiency syndrome in the United States, 1982 through 1991. Transfusion, 33, 890-893.
6. Aach R.D., Szmuness W., Mosley J.W., Hollinger B., Kahn R.A., Stevens C.E., Edwards V.M., Werch J. (1981) Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The transfusion transmitted viruses study. N. Engl. J. Med., 304, 989-994.
7. Donegan E., Stuart M., Niland J.C. et al. and the Transfusion Safety Study Group (1990) Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann. Int. Med., 113, 733-739.
8. Nelson K.E., Donahue J.G., Munoz A. (1992) Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery ; a multicenter study of HIV-1 and HTLV-I/II infections. Ann. Int. Med., 117, 554-559.
9. Alter H.J., Purcell R.H., Holland P.V., Alling D.W., Koziol D.E. (1981) Donor transaminase and recipient hepatitis. JAMA, 246, 630-634.
10. Alter H.J., Epstein J.S., Swenson S.G., VanRaden M.J., Ward J.W., Kaslow R.A., Menitove J.E., Klein H.G., Sandler S.G., Sayers M.H., Hewlett I.K., Chernoff A.I. and the HIV-Antigen Study Group (1990) Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors - an assessment of the efficacy of testing in donor screening. N. Engl. J. Med., 323, 9, 1312-1317.
11. Busch M.P., Eble B.E., Khayam-Bashi H., Murphy E.L., Heilbron D., Kwok S., Sninsky J.J., Perkins H.A., Vyas G.N. (1991) Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N. Engl. J. Med., 325, 1-5.
12. Kleinman S., Alter H., Busch M., Holland P., Tegtmeier G., Nelles M., Lee S., Page E., Wilber J., Polito A. (1992) Increased detection of hepatitis C virus (HCV) - infected blood donors using a multiple antigen HCV enzyme immunoassay. Transfusion, 32, 805-813.
13. Aach R.D., Stevens C.E., Hollinger F.B., Mosley J.W., Peterson D.A., Taylor P.E., Johnson R.G., Barbosa L.H., Nemo G.J. (1991) Hepatitis C virus infection in post-transfusion hepatitis : an analysis with first- and second-generation assays. N. Engl. J. Med., 325, 1325-1329.
14. Zuck T.F., Thomson R.A., Schreiber G., Gilcher R.O., Kleinman S.H., Murphy E.L., Ownby H.E., Williams A.E., Busch M.P., Smith J.W., Nemo G.J., Hollingsworth C.G., for the REDS Study Group (1995) The Retrovirus Epidemiology Donor Study (REDS) : rationale and methods. Transfusion (in press).
15. Busch M.P., Laycock M., Kleinman S.H., Wages J.W. Jr., Calabro M., Kaplan J.E., Khabbaz R.E., Hollingsworth C.G., and the Retrovirus Epidemiology Donor Study (REDS) (1994) Accuracy of supplementary serological testing for human T-lymphotropic virus (HTLV) types I and II in US blood donors. Blood, 83, 1143-1148.
16. Korelitz J., Williams A.E., Busch M.P., Zuck T.F., Ownby H., Natijas L.J., Wright D.J. (1994) Demographic characteristics and prevalence of serological markers among donors who use the confidential unit exclusion (CUE) process. Transfusion, 34, 870-876.
17. Hoofnagle J.H., Seeff L.B., Buskell-Bales Z., Gerety R.J., Tabor E. (1978) Serologic responses in HB. Chapter in Viral Hepatits : A Contemporary Assessment of Etiology. Epidemiology, Pathogenesis and Prevention. Vyas G.N., Cohen S.N., Schmid R., eds The Franklin Press, Philadelphia PA, 219-242.
18. Mimms L.T., Mosley J.W., Hollinger F.B., Aach R.D., Stevens C.E., Cunningham M., Vallari D.V., Barbosa L.H., Nemo G.J. (1993) Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. Br. Med. J., 307, 6912, 1095-1097.
19. Petersen L.R., Satten G.A., Dodd R., Busch M., Kleinman S., Grindon A., Lenes B. and the HIV Seroconversion Study Group (1994) Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion, 34, 283-289
20. Busch M.P., Lee L.L.L., Satten G.A., Henrard D.R., Farzadegan H., Nelson K.E., Read S., Dodd R.Y., Petersen L.R. (1995) Time course of detection of viral and serological markers preceding HIV-1 seroconversion ; implications for blood and tissue donor screening. Transfusion, 35, 91-97
21. Manns A., Wilks R.J., Murphy E.L. et al. (1992) A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int. J. Cancer., 51, 886-891.
22. Lelie P.N., Cuypers H.T.M., Reesink H.W. et al. (1992) Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J. Med. Virol., 37, 203-209
23. Busch M.P., Korelitz J.J., Kleinman S.H., Lee S.R., Aubuchon J.P., Schreiber G.B. and the Retrovirus Epidemiology in Donors Study (REDS) (1995) Declining yield of alanine aminotransferase for screening of blood donors for prevention of post-transfusion hepatitis B and C virus infection. Transfusion (in press).
24. Jagodzinski L., Kraus F., Garrett P., Schumacher R., Nanak M. (1994) Detection of hepatits B viral sequences in early HBV infections. Abstract S-148. Transfusion, 34, 105, 37.
25. Busch M.P. (1995) Applications of Molecular Biology to Infectious Disease Screening of Blood Donors. In : Molecular Genetics in Diagnosis and Research. Allen R., AuBuchon J.P. American Assn. of Blood Banks, Bethesda MD (in press).
26. Alter M.J., Margolis H.S., Krawczynski K. et al. (1992) Natural history of community acquired hepatitis C in the Onited States. N. Engl. J. Med., 327, 1899-1905.
27. AuBuchon J.P., Birkmeyer J.D., Busch M.P. (1995) Cost-Effectiveness of Expanded HIV Test Protocols for Donated Blood. N. Engl. J. Med. (submitted).
28. Food and Drug Administration (FDA), Center for Biologies Evaluation and Research (CBER). August 8, 1995, Recommendations for Donor Screening with a Licensed Test for HIV-1 Antigen.